Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 12, 2021Journal of NeuroinflammationOpen Access

Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response

View Full Paper
Ask AI
Bookmark
Share

Authors

MPMarius PiepkeUniversität HamburgBCBettina Hjelm ClausenUniversity of Southern DenmarkPLPeter LudewigUniversität Hamburg

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Piepke et al. (2021) studied this question.

synapsesocial.com/papers/6a1c57ef4ebd09f3dfa9bafehttps://doi.org/10.1186/s12974-021-02316-7
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1IL-17 targeted therapies for psoriasis2013 · 164 citations
  2. 2Interleukin‐10 release from astrocytes suppresses neuronal apoptosis via the TLR 2/ NF κB pathway in a neonatal rat model of hypoxic‐ischemic brain damage2017 · 24 citations
  3. 3Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice2008 · 323 citations
  4. 4Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke2012 · 474 citations